Limbix to Present Efficacy Data From SparkRx Digital Therapeutic Clinical Trial in Adolescents With Moderate to Severe Depressive Symptoms at 2021 American Academy of Pediatrics National Conference & Exhibition Virtual Experience
Limbix , a prescription digital therapeutic company developing mental health treatments for adolescents, today announced Benjamin Alouf, M.D., chief medical officer of Limbix, will present clinical data demonstrating the efficacy of SparkRx in adolescents with moderate to severe depressive symptoms at the upcoming American Academy of Pediatrics (AAP) National Conference.